African Equity Empowerment Investments Limited Overview
AEEI is a Cape Town-based, majority black-owned and black-controlled investment holding company. Its main asset is a 56.23% stake in Premier Fishing and Brands (PFB), a vertically integrated fishing and aquaculture group founded in 1952 that holds 15-year rights across squid, rock lobster, hake, small pelagics and an abalone farm. Around this core sits a set of small operating businesses: Global Command and Control Technologies (defence command-and-control), Orleans Cosmetics and AfriNat (health and beauty), ESP Afrika (organiser of the Cape Town International Jazz Festival) and Tripos Travel. It also holds a dormant biotechnology portfolio and a 60% equity-accounted interest in telecoms integrator SGT Solutions. Between 2023 and 2024 AEEI unbundled ICT group AYO, sold its 30% stake in BT South Africa for R290m, and delisted from the JSE at R1.15 per share. The result is a much smaller, privately controlled, fishing-dominated holding company. Its strategic agenda is shaped by long-running litigation over bank account closures that affects the wider Sekunjalo group.
The company's own description
AEEI describes itself as a diversified investment and empowerment company with holdings in fishing and brands, technology, events and tourism, health and beauty, and biotherapeutics. It presents all of these as supporting Broad-Based Black Economic Empowerment (B-BBEE) and small, medium and micro-enterprises, alongside strategic investments, some with international partners [S5, S13]. Its stated purpose is to empower previously disadvantaged people through job creation and to grow shareholder wealth through strategic investment. Its mission statement says AEEI "empowers people through profits and partnerships" [S13]. The stated strategy is to grow through acquisitions and to make better use of the existing portfolio by increasing the net asset base and improving cash generation [S13].
The 2024 scheme circular describes the business model as follows. AEEI acquires control of most of its operating investments and also holds non-controlling stakes in strategic investments and associates. It adds value through management expertise, networks, influence over business processes and synergies between holdings [S5].
Independent characterisation
On the evidence of FY2019 to FY2023, AEEI has been less a classic investment holding company than a consolidating conglomerate whose reported numbers were dominated by one subsidiary at a time:
FY2019 to FY2023 (AYO era): ICT subsidiary AYO Technology Solutions made up 69% to 84% of group revenue. AYO also held most of the cash. Group cash of R3.36bn at FY2020 [S2] largely reflected the R4.3bn the Public Investment Corporation (PIC) invested in AYO at its 2017 listing [S47]. Interest on that cash (investment revenue of R247m in FY2020 [S2]) was a large share of group pre-tax profit.
Post-July 2023 (fishing era): After the AYO unbundling, continuing revenue was R734m. The fishing and brands segment contributed 77% of it and all of the positive segment profit except a small GC2T contribution [S1].
Revenue model. Practically all consolidated revenue is product revenue: frozen and live seafood, abalone, fishmeal, organic fertiliser, imported cosmetics and AfriNat agro-products. Smaller streams are project and service revenue (GC2T defence contracts, events and ticketing at ESP Afrika, travel commissions at Tripos) and holding-company income (dividends, interest, management fees). PFB pays AEEI a management fee of 1.25% of budgeted revenue, capped at R7.5m a year [S5]. AEEI has no material subscription or licensing revenue. The biotechnology intellectual property (dendritic cell vaccine) is pre-revenue [S1].
Value-chain position.
Fishing: fully vertically integrated, covering rights holding, vessels, processing factories, marketing and export [S13].
Abalone: land-based aquaculture producing live and canned product, mainly for Far East markets [S45].
Health and beauty: import, distribution and local manufacturing of natural products [S3].
Defence technology: original equipment manufacturer and systems integrator [S1].
Events: owner-operator of festival intellectual property [S1].
Customer types and end-markets.
-
Export seafood buyers. Squid and abalone go mainly to Europe and Asia; the company refers to strong export demand for squid and to Far East abalone markets [S1, S45].
-
Domestic retail and food service for hake, pelagics and lobster.
-
Commercial agriculture, notably citrus, for AfriNat [S1].
-
Pharmacy and beauty retail for Orleans (the Nuxe brand is about 40% of its sales) [S1].
-
The South African National Defence Force, Armscor, the African Union and Middle East customers for GC2T [S1].
-
Consumers and corporate sponsors for ESP Afrika [S1].
What changed in 2023–2024
| Change | Effect | Source |
|---|---|---|
| AYO unbundled 31 Jul 2023 (1 AYO share per 2.89 AEEI shares) | Removed R2.1bn of revenue (11 months) and R1.09bn of net assets. R515m loss on settlement of the dividend-in-specie liability | S1, S8 |
| PFB delisted 1 Aug 2023 | Premier became a private subsidiary. AEEI's stake is 56.23% | S32, S5 |
| BTSA 30% sold to BTSA for R290m (effective 28 Dec 2023) | Ended the 2021 call-option dispute. R702m impairment taken in FY2023 | S1, S5 |
| AEEI delisted 16 Apr 2024 | Repurchase offer to minorities at R1.15/share (maximum R166.0m) | S5, S6 |
Strategy
Stated strategy over time
| Period | Strategy | Source |
|---|---|---|
| 2015 to 2020 | "Vision 2020 Vision": five-year growth plan through acquisitions and organic growth. Management said all goals were achieved | S11, S3 |
| 2,019 | Preparing a "Vision 2025 Vision" strategy (not subsequently published in detail) | Chairman's report, IR 2019 |
| FY2021 | Focus on cost savings and operational efficiency; possible disposal of non-performing assets. Decided again not to become a passive investment holding company and to stay hands-on | S2 |
| FY2023 to 2024 | Three priorities: (1) resolve banking problems and rebuild bank relationships; (2) delist to cut listing costs and speed up decisions; (3) consolidate the portfolio by selling non-key assets and growing profitable core assets, while pursuing growth and partnerships within acceptable risk limits | S1, S5 |
| Post-AYO (Aug 2023) | CEO said AEEI would focus on growing its remaining companies and seek new acquisitions | S18 (Independent Media) |
Strategic initiatives in the last 24 months (Oct 2024 to Oct 2026)
Since delisting in April 2024, AEEI has not published strategy updates, investor presentations or financial targets. The public record for the period is limited to:
Banking access: continued litigation and regulatory action by the Sekunjalo group, of which AEEI's entities are part. Nedbank closed Sekunjalo-entity accounts in December 2024, and the Tribunal declined interim relief on 9 January 2025 [S27].
Fishing and abalone: In November 2024 Sekunjalo's chairman held a town hall at the Gansbaai abalone farm and restated long-term commitment to it despite thin profitability [S34] (Independent Media).
Events: ESP Afrika staged CTIJF 2025 (24 to 26 April 2025, about 24,000 attendees) and CTIJF 2026 (27 to 28 March 2026, 23rd edition) with a new visual identity [S35].
The following are all not publicly disclosed: any transformation programme, cost programme, new business launch, partnership, platform investment or sustainability-linked commitment by AEEI in the period.
Management guidance and medium-term targets
None publicly disclosed. AEEI did not give quantified financial targets in its FY2021 to FY2023 results, and published nothing after delisting.
Products & Services
Fishing and brands (Premier Fishing and Brands; 56.23% held)
| Product line | Description and capability | Target customer | Notes | Source |
|---|---|---|---|---|
| Squid (Talhado and Premier) | Jig-caught chokka squid. Talhado runs sea and land-based freezing in Gqeberha (Port Elizabeth) harbour and has an international sales network | Export buyers, mainly Europe | Most cyclical line. Revenue rose from R141m to R206m in FY2021 [S2] and fell 50% in FY2022 [S45]. Premier owns 80.65% of Talhado since early 2023 [S33] | S2, S33, S45 |
| West Coast rock lobster | Rights-based harvesting and processing | Export and local | Hurt by lower total allowable catch in FY2019; broke even at EBITDA level in FY2023 after cost cuts | S3, S1 |
| South Coast rock lobster | Deep-water lobster | Export | Volumes and prices improved in FY2023 | S1 |
| Hake (deep-sea trawl and longline) | Rights in both hake sub-sectors | Local and export | Strong in FY2022 and FY2023 | S1, S45 |
| Small pelagics (anchovy, sardine) and fishmeal | Pelagic rights; fishmeal output | Fishmeal and feed markets | Pelagic did well in FY2023 | S1, S5 |
| Abalone (Marine Growers) | Land-based farm at Gansbaai producing Haliotis midae; live and canned product | Far East export | Farm operating for over 18 years. Sekunjalo's chairman publicly said it is not very profitable (Nov 2024) [S34] | S34, S45 |
| Seagro organic fertiliser | Fish-derived organic fertiliser range | Agriculture | Called a strong performer in FY2023 | S1, S45 |
| Fleet and facilities | More than 30 fishing vessels; owned factories in two provinces | — | Fleet count per FY2022 results | S45, S13 |
Pricing model: Commodity and export pricing, sensitive to the USD/ZAR rate (FY2023 sales benefited from better-than-expected exchange rates [S1]). Specific prices are not publicly disclosed.
Technology (continuing): Global Command and Control Technologies (GC2T)
| Offering | Description | Customers / contracts | Source |
|---|---|---|---|
| "Enabled Awareness" command and control (C2/C3IS) systems | Company says it is the only OEM of such systems on the African continent | African Union C3IS support and maintenance contract for the Multinational Joint Task Force (MNJTF) | S1 |
| South African Air Force UIS (formerly CMSP) | Contract converted through Armscor | SAAF / Armscor | S1 |
| Middle East and Saudi Arabia projects | Delivered via ETION Create and direct Saudi contracts | Middle East defence | S1 |
| SANDF / DoD sub-contracts | Via Denel, e.g. LEGEND (Fellowship) | SANDF | S1 |
| GC2T (ZAR Mn) | FY2022 | FY2023 |
|---|---|---|
| Revenue | 45 | 96 |
| Pre-tax result | -22 | 2 |
Performance:
FY2023 was GC2T's first profitable year [S16, S1].
Technology (associate): SGT Solutions via Mainstreet 1653 (60%)
| SGT Solutions (ZAR Mn) | FY2022 | FY2023 |
|---|---|---|
| Revenue | 346 | 346 |
| Pre-tax profit | 23 | 22 |
SGT designs, procures, deploys and maintains telecommunications networks for fixed, mobile and converged operators. It also develops DC power solutions for telecoms sites [S1, S5].
AEEI equity-accounted R9.4m of SGT profit in FY2023 [S1].
Technology (exited): AYO Technology Solutions
AYO offered ICT services, software, connectivity, distribution of voice and AV equipment (Kathea: Jabra, Polycom, Plantronics, Logitech, Yealink) and cybersecurity (Puleng, sold September 2021) [S2]. It was unbundled on 31 July 2023 [S1].
Health and beauty
| Business | Description | FY2023 metrics | Source |
|---|---|---|---|
| Orleans Cosmetics | Imports and distributes European cosmetic and fragrance brands. Nuxe is about 40% of sales, and Nuxe sales grew 16.7% in FY2023 | Revenue about R38m (+10%); two price increases taken | S1 |
| AfriNat | Natural products in three areas: (i) agriculture, pre- and post-harvest; (ii) hygiene and sanitation; (iii) food preservation | Revenue R12.1m (FY2022: R11.8m). Expanding to clients in the northern provinces | S1 |
Events and tourism
| Business | Description | Metrics | Source |
|---|---|---|---|
| ESP Afrika | Owner-organiser of the Cape Town International Jazz Festival (CTIJF, since 2000) and the Festival of Lights | FY2023 revenue about R7m (FY2022: nil). The CTIJF returned in 2024 to 2026 | S1, S35 |
| Tripos Travel | Corporate and leisure travel management | FY2023 revenue R20m (FY2022: R17m) | S1 |
| Magic 828 (former) | AM radio station. Listenership grew from 187,000 to 240,000 between Aug 2019 and Aug 2020 | R10.2m goodwill impairment in FY2022. Third-party descriptions call it a former holding | S43, S1 |
Biotechnology / biotherapeutics
| Programme | Description | Status | Source |
|---|---|---|---|
| Dendritic cell vaccine (DCV) | Cancer immunotherapy (breast cancer trials were planned with University of Cape Town partners in FY2019) and work on extremely drug-resistant TB | Minimal progress in FY2021 to FY2023 because of lack of funding. IP registrations maintained in new territories. R139.5m intangible impairment in FY2023 | S3, S2, S1 |
| Bioclones / Genius Biotherapeutics; Ribotech | Biopharmaceutical production platforms (historical) | Commercial status not publicly disclosed | S3, S39 |
Strategic and financial investments
| Investment | Status | Source |
|---|---|---|
| BT Communications Services South Africa (30%) | Sold for R290m, effective 28 Dec 2023 | S5 |
| Sygnia Ltd (listed) | Small stake; value fell about R2m in FY2023 | S1 |
| African Legend Investments (ALI) | Value fell R5.4m in FY2023 | S1 |
| Saab Grintek Defence (minority) | Listed as a strategic investment in FY2019; not mentioned in FY2023 corporate commentary; current status not publicly disclosed | S3, S1 |
| Pioneer Foods; Quantum Foods | Sold 15 Mar 2019 and 27 May 2019 | S3 |
Financial Narrative
Basis of preparation:
-
IFRS, reported in R'000 and converted here to ZAR M.
-
FY2019 [S3]; FY2020 and FY2021 [S2]; FY2022 as restated and FY2023 [S1], with FY2022 originals from [S4].
-
FY2022 and FY2023 totals add together continuing and discontinued (AYO) operations so the series is comparable.
-
"Derived" means calculated by the analyst from disclosed line items.
-
Blank cells = not publicly disclosed in the documents reviewed.
Income statement
Notes to 6.1:
-
FY2023 EPS and HEPS are derived by combining continuing and discontinued figures: (R1,426.6m) ÷ 491.02m shares = -290.54c; R103.5m + (R167.0m) = (R63.5m) ÷ 491.02m = -12.92c. Reporting inconsistency: [S1] labels continuing basic EPS as "(2.54) cents" and continuing HEPS as "0.21 cents". Arithmetic on the disclosed rand amounts gives about -253.7c and +21.1c. The disclosed figures appear to be in rand, not cents, and are mislabelled.
-
FY2020 EPS and HEPS are as restated in [S2] (1.93c and 0.93c). The FY2020 CEO report [S11] gave EPS of 3.74c, and a trading statement gave HEPS of 0.94c [S10]. [S2] also shows FY2020 headline earnings as R4.6m in the highlights but R11.2m in the reconciliation table. These discrepancies are unresolved in public documents.
-
FY2019 EPS: the results advert gives -313.55c [S3]. The FY2020 CEO report cites the FY2019 comparative as -283.30c [S11]. Discrepancy unresolved.
-
FY2021 HEPS was later restated to -22.07c [S4].
-
FY2022 figures are the original reported totals [S4]: LBT R330.8m, basic LPS 45.78c, HLPS 37.16c. FY2022 gross profit, investment income and associates are derived from restated continuing plus discontinued amounts [S1].
-
FY2023 normalised PBT combines continuing R122.1m and discontinued -R377.3m [S1]. FY2023 normalised HEPS combines continuing 22.29c and discontinued 0.40c [S1].
-
Dividends: FY2019 total 17c (final 6c) [S3]. FY2020 total 30c (final 20c) [S2]. FY2021 total 40c (final 10c) [S2]. No dividend declared for FY2022 or FY2023 [S4, S1].
-
EBITDA is not reported by the company. The FY2022 derived EBITDA is omitted because the restated segment depreciation figures are internally inconsistent.
Margin profile
Derived from [S1] to [S4]. The FY2022 continuing gross margin uses restated gross profit of R199.6m on R578.6m revenue.
Trend commentary.
FY2019: Revenue rose 243% to R2.4bn because AYO was re-consolidated and AYO bought Sizwe, SGT and GC2T. Those acquisitions added R1.9bn of revenue [S3]. Reported pre-tax loss was R2.39bn because of the R2.48bn deemed-disposal loss on re-consolidation. Normalised PBT was R240m and HEPS was 91.16c [S3].
FY2020: Revenue peaked at R3.43bn as the IT division grew both organically and through acquisitions [S43]. Earnings quality was weak:
-
PBT of R111m was smaller than investment revenue of R247m and associate income of R75m [S2].
-
Taxation of R92m absorbed most of the PBT, leaving R18.9m of profit [S2].
-
The operating businesses, in aggregate, were loss-making before interest and associate income. This is the clearest early sign of the later decline.
FY2021: Revenue fell 32% as AYO lost major contracts and clients cut infrastructure spending [S2]. Investment revenue fell to R162m as cash fell from R3.36bn to R2.34bn [S2]. Dividends of R484.7m left the group, R247.3m to AEEI shareholders and R237.4m to minorities [S2], even as the group recorded a R265m loss. Fishing recovered on squid [S2].
FY2022: Revenue was flat at R2.33bn. Fishing fell 17% on squid scarcity, offset by a 6% IT improvement [S45, CEO report 2022]. Basic loss per share widened to 45.78c [S4].
FY2023: Two once-off charges dominate the R1.78bn pre-tax loss: the R702.5m BTSA impairment and the R514.8m dividend-in-specie settlement loss on unbundling AYO [S1]. Excluding these, the continuing fishing-led group earned normalised PBT of R122.1m on R734.2m revenue, a 16.6% margin [S1].
Balance sheet
Notes to 6.3:
-
FY2019 cash is cash at the start of FY2020 per the cash flow statement [S2]. FY2019 total and attributable equity are the 1 Sep 2019 opening balances [S2].
-
Debt is derived as other financial liabilities, lease liabilities, bank overdraft, loans from shareholders and loans from group or related companies [S1, S2]. AEEI reports no conventional bank borrowings, consistent with its restricted access to banking.
-
FY2023 working capital excludes the R290m BTSA asset held for sale. FY2023 related-party loans payable were R123.3m [S1].
Balance-sheet commentary.
Cash depletion: Group cash fell from R3.84bn (FY2019) to R0.24bn (FY2023). The drivers were:
-
Losses and working-capital outflows at AYO. AYO's FY2023 operating cash outflow was R985m [S1].
-
Dividends, especially R509m in FY2021.
-
Deconsolidation of AYO's remaining cash (R209.7m) at unbundling [S1].
Outside shareholders' claim on the balance sheet: Non-controlling interests were close to half of total equity through FY2022, reflecting AYO's large outside shareholder base, chiefly the PIC [S1, S2].
How AEEI reports NAV per share: AEEI's published NAV per share is calculated on total equity including NCI. For example, FY2023: 246.07c × 491.02m shares = R1,208m = total equity [S1]. On an attributable basis, NAV per share was 96.6c at FY2023, not 246.07c. This matters for judging the R1.15 exit price.
Cash flow
Notes to 6.4:
-
Sources: [S1], [S2], [S3].
-
FY2022 and FY2023 capex combine continuing cash-flow capex with discontinued segment capex [S1].
-
FY2022 dividends to NCI are continuing operations only; the discontinued amount is not separately disclosed.
-
FY2023 includes R95m paid to buy the additional Talhado stake from a non-controlling interest [S1].
-
The April 2024 scheme buyback (maximum R166.0m) falls in FY2024, for which no cash flow statement has been published.
Ratio analysis
Notes to 6.5:
-
All ratios are derived from [S1], [S2], [S3].
-
ROIC and net debt/EBITDA are not meaningful: AEEI was in net cash every year, and its derived operating result was negative from FY2020 to FY2023.
-
Negative interest-coverage values show losses before finance costs, not a solvency problem; finance costs are mostly lease interest.
-
The FY2023 cash conversion cycle uses continuing operations only (DIO 56.4, DSO 50.7, DPO 88.7 days).
-
The FY2022 cycle uses combined continuing and discontinued balances; DSO of 137.6 days reflects AYO receivables of R1.18bn.
-
FY2023 asset turnover is distorted by AYO's 11 months of revenue against a year-end balance sheet without AYO.
Ratio commentary.
Returns: Over the four years for which they can be calculated (FY2020 to FY2023), ROE and ROA never exceeded 0.3%. The only positive return year was FY2020, and that profit came mostly from interest income on PIC-sourced cash at AYO.
Liquidity: Very high through FY2022 (current ratio above 4x). After the AYO deconsolidation it fell to a still-comfortable 2.8x, and to 4.4x including the R290m held-for-sale asset.
Leverage: Negligible throughout.
Earnings capacity post-unbundling: The FY2023 continuing business generated R74.0m of operating cash flow and R33.6m of free cash flow after R40.5m of capex [S1]. That is the best public guide to its standalone cash-generating capacity.
Revenue CAGR: Reported revenue grew at a 4.3% CAGR from FY2019 to FY2023, but the figure is distorted because AYO is excluded after FY2023. On a like-for-like non-technology perimeter, FY2018 revenue of R700.7m [S3] compares with R734.2m of FY2023 continuing revenue [S1], close to flat over five years.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | AEEI interest | Accounting | Business | Source |
|---|---|---|---|---|
Premier Fishing and Brands Ltd (PFB) | 56.23% | Subsidiary | Vertically integrated fishing and aquaculture | S5 |
Talhado Fishing Enterprises (via Premier Fishing SA) | 80.65% held by PFSA | Subsidiary of PFB | Squid (largest SA squid player per company) | S33 |
Marine Growers (Pty) Ltd | Subsidiary of PFB (% not disclosed) | Subsidiary | Abalone farm, Gansbaai | S5, S34 |
Global Command and Control Technologies (GC2T) | — | Subsidiary (the "continuing technology" segment) | Command-and-control OEM | S1 |
Mainstreet 1653 (Pty) Ltd (holds 100% of SGT Solutions) | 60% (AYO 40%) | Associate from Aug 2023 (AYO appoints the board majority) | Telecoms turnkey integrator | S1, S5 |
Orleans Cosmetics (Pty) Ltd | — | Subsidiary | Cosmetics import and distribution | S1 |
AfriNat (Pty) Ltd | — | Subsidiary | Natural agri, hygiene and food-preservation products | S1 |
ESP Afrika (Pty) Ltd | 100% (indirect) | Subsidiary | Events (CTIJF) | S5 |
Tripos Travel (Pty) Ltd | — | Subsidiary | Corporate and leisure travel | S1 |
African Biotechnology and Medical Innovation Investments (Bioclones / Genius Biotherapeutics, Ribotech) | — | Subsidiary | Biotherapeutics R&D | S3, S13 |
Kilomax / Kilomix Investments | 100% | Subsidiaries | Former BTSA holding vehicles | S5 |
Sygnia Ltd; African Legend Investments | Minority | Fair value | Strategic investments | S1 |
“—” = not publicly disclosed.
Segment revenue (ZAR Mn, external)
| Segment revenue (ZAR Mn, external) | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
Fishing and brands | 574.0 | 447.4 | 569.9 | 470.4 | 565.5 |
Technology total (AYO plus GC2T) | 1,665.4 | 2,885.2 | 1,700.8 | 1,799.8 | 2,199.5 |
Technology: AYO group (discontinued in FY2023) | — | — | — | 1,754.9 | 2,103.9 |
Technology: GC2T (continuing) | — | — | — | 44.9 | 95.6 |
Health and beauty | 42.2 | 45.4 | 44.5 | 45.1 | 49.1 |
Biotechnology | 0 | 0 | 0 | 0 | 0 |
Events and tourism | 79.7 | 33.9 | 7.4 | 10.6 | 20.4 |
Corporate | 40.5 | 15.6 | 16.6 | 7.5 | 3.6 |
Group revenue incl. discontinued | 2,401.8 | 3,427.6 | 2,339.2 | 2,333.5 | 2,838.2 |
Segment profit before tax (ZAR Mn)
| Segment profit before tax (ZAR Mn) | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
Fishing and brands | 101.3 | 0.3 | 13.0 | 18.4 | 78.0 |
Technology total | 123.8 | 115.1 | -193.6 | -346.1 | -521.3 |
Technology: AYO group (discontinued) | — | — | — | — | -534.4 |
Technology: GC2T (continuing) | — | — | — | — | 13.1 |
Health and beauty | 1.1 | 0.5 | 5.8 | -5.4 | -0.2 |
Biotechnology | -67.8 | -6.6 | -0.9 | -0.7 | -140.8 |
Events and tourism | -42.3 | -5.4 | -7.7 | -2.9 | -15.7 |
Corporate | -2,504.1 | 7.2 | 2.6 | 5.8 | -1,175.7 |
Group profit before tax | -2,388.1 | 111.2 | -180.8 | -330.8 | -1,775.8 |
Segment Margins & Growth (%) and Revenue by Segment (%)
| Segment metric (%) | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
Fishing PBT margin | 17.6 | 0.1 | 2.3 | 3.9 | 13.8 |
Technology PBT margin | 7.4 | 4.0 | -11.4 | -19.2 | -23.7 |
Health and beauty PBT margin | 2.5 | 1.0 | 13.1 | -11.9 | -0.3 |
Events and tourism PBT margin | -53.1 | -15.8 | -103.6 | -27.5 | -76.9 |
Fishing share of group revenue | 23.9 | 13.1 | 24.4 | 20.2 | 19.9 |
Technology share of group revenue | 69.3 | 84.2 | 72.7 | 77.1 | 77.5 |
Health and beauty share of group revenue | 1.8 | 1.3 | 1.9 | 1.9 | 1.7 |
Events and tourism share of group revenue | 3.3 | 1.0 | 0.3 | 0.5 | 0.7 |
Fishing revenue growth YoY | — | -22.1 | 27.4 | -17.4 | 20.2 |
Technology revenue growth YoY | — | 73.2 | -41.1 | 5.8 | 22.2 |
Segment Overview
| Segment | Share of continuing revenue |
|---|---|
Fishing and brands | 77.0% |
GC2T (technology) | 13.0% |
Health and beauty | 6.7% |
Events and tourism | 2.8% |
Corporate | 0.5% |
Income statement (ZAR Mn)
| Income statement (ZAR Mn) | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
Revenue (incl. discontinued) | 2,401.8 | 3,427.6 | 2,339.2 | 2,333.5 | 2,838.2 |
Revenue: continuing ops as reported in FY2023 | — | — | — | 578.6 | 734.2 |
Revenue growth YoY (%) | 242.8 | 42.7 | -31.8 | -0.2 | 21.6 |
Gross profit | — | 814.5 | 679.8 | 592.5 | 627.1 |
Operating result before investment income, associates and finance costs (derived) | — | -179.2 | -372.8 | -523.4 | -1,945.1 |
EBITDA (derived: PBT + finance costs + D&A) | — | 233.8 | -60.0 | — | -1,679.0 |
Investment revenue / finance income | — | 247.3 | 162.4 | 142.5 | 143.9 |
Income from equity-accounted investments | — | 74.8 | 52.5 | 72.5 | 51.3 |
Finance costs | — | 31.8 | 22.9 | 22.4 | 25.8 |
Profit before tax | -2,388.1 | 111.2 | -180.8 | -330.8 | -1,775.8 |
Normalised profit before tax (company definition) | 239.8 | 309.3 | -104.9 | — | -255.2 |
Taxation (charge negative) | — | -92.3 | -84.5 | -31.4 | 46.9 |
Profit/(loss) for the year | — | 18.9 | -265.4 | -362.2 | -1,728.8 |
Total comprehensive income/(loss) | -1,438.0 | 18.4 | -262.2 | -362.8 | -1,730.6 |
Profit/(loss) attributable to AEEI shareholders | — | 10.0 | -133.1 | -224.2 | -1,426.6 |
Basic EPS (cents) | -313.55 | 1.93 | -26.48 | -45.78 | -290.54 |
Diluted EPS (cents) | -313.55 | 1.93 | -26.48 | -45.78 | -290.54 |
HEPS (cents) | 91.16 | 0.93 | -25.39 | -37.16 | -12.92 |
Normalised HEPS (cents) | 100.22 | 35.61 | -7.45 | -2.56 | 22.69 |
Dividend declared per share (cents) | 17 | 30 | 40 | 0 | 0 |
Margin (%)
| Margin (%) | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
Gross margin | — | 23.8 | 29.1 | 25.4 | 22.1 |
Gross margin, continuing ops only | — | — | — | 34.5 | 44.1 |
EBITDA margin (derived) | — | 6.8 | -2.6 | — | -59.2 |
Pre-tax margin | -99.4 | 3.2 | -7.7 | -14.2 | -62.6 |
Normalised pre-tax margin | 10.0 | 9.0 | -4.5 | — | -9.0 |
Normalised pre-tax margin, continuing ops | — | — | — | -0.2 | 16.6 |
Net margin (profit for year / revenue) | — | 0.6 | -11.3 | -15.5 | -60.9 |
Balance Sheet
| Balance sheet (ZAR Mn) | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
Total assets | 7,403.4 | 7,211.7 | 6,449.8 | 6,029.8 | 1,712.0 |
Cash and cash equivalents | 3,836.5 | 3,358.0 | 2,343.9 | 1,349.9 | 235.7 |
Total debt incl. leases (derived) | — | 129.4 | 229.0 | 193.2 | 154.2 |
Short-term debt incl. current leases and overdraft (derived) | — | 36.4 | 49.2 | 54.1 | 51.7 |
Long-term debt incl. non-current leases (derived) | — | 93.1 | 179.8 | 139.1 | 102.5 |
of which lease liabilities | — | 97.5 | 168.9 | 186.6 | 27.5 |
Net debt (negative = net cash, derived) | — | -3,228.6 | -2,114.9 | -1,156.7 | -81.6 |
Total equity | 6,403.7 | 6,169.5 | 5,413.7 | 4,877.4 | 1,208.3 |
Equity attributable to AEEI shareholders | 3,315.3 | 3,199.6 | 2,831.0 | 2,569.5 | 474.2 |
Non-controlling interests | 3,088.4 | 2,969.8 | 2,582.7 | 2,307.9 | 734.1 |
Goodwill and intangible assets | — | 472.6 | 619.1 | 504.4 | 130.6 |
Investments in associates | — | 866.4 | 896.6 | 935.6 | 72.9 |
Working capital (current assets less current liabilities) | — | 3,760.3 | 3,006.2 | 2,286.5 | 320.3 |
Total liabilities | — | 1,042.2 | 1,036.1 | 1,152.3 | 503.7 |
Assets held for sale | — | 0 | 59.8 | 0 | 290.0 |
Cash flow (ZAR Mn)
| Cash flow (ZAR Mn) | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
Net cash from operating activities (incl. discontinued) | 143.1 | 199.6 | -195.6 | -207.5 | -911.2 |
Net cash from operating activities, continuing ops | — | — | — | -29.6 | 74.0 |
Capex: PPE plus intangibles (derived) | — | 101.1 | 86.0 | 44.1 | 50.5 |
Free cash flow (derived, OCF less capex) | — | 98.6 | -281.6 | -251.6 | -961.7 |
Dividends paid to AEEI shareholders | — | 78.6 | 247.3 | 48.3 | 0 |
Dividends paid to non-controlling interests | — | 106.4 | 237.4 | 13.0 | 35.0 |
Share buybacks | — | 0.3 | 0 | 0 | 0 |
Total cash movement | — | -483.9 | -1,008.7 | -997.0 | -1,112.7 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
ROE on average attributable equity (%) | — | 0.3 | -4.4 | -8.3 | -93.7 |
ROA, profit for year / average total assets (%) | — | 0.3 | -3.9 | -5.8 | -44.7 |
Current ratio (x) | — | 5.98 | 6.17 | 4.23 | 2.77 |
Total debt / total equity (%) | — | 2.1 | 4.2 | 4.0 | 12.8 |
Interest coverage, (PBT + finance costs) / finance costs (x) | — | 4.5 | -6.9 | -13.8 | -67.8 |
Asset turnover, revenue / average total assets (x) | — | 0.47 | 0.34 | 0.37 | 0.73 |
Cash conversion cycle (days, year-end balances) | — | 30.5 | 43.7 | 97.8 | 18.4 |
Attributable NAV per share (cents, derived) | 675.2 | 651.6 | 576.6 | 523.3 | 96.6 |
Reported NAV per share incl. NCI (cents) | 1,294.69 | 1,256.46 | 1,102.54 | 993.32 | 246.07 |
Geographic revenue (ZAR Mn)
| Geographic revenue (ZAR Mn) | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
Group revenue, all geographies | 2,401.8 | 3,427.6 | 2,339.2 | 2,333.5 | 2,838.2 |
Share Price & Returns
| Reference point | Price (ZAR per share) | Implied equity value, 491.02m shares (ZAR Mn) | Source |
|---|---|---|---|
Close before firm intention (13 Oct 2023) | 0.90 | 441.9 | S5 |
Close on announcement day (16 Oct 2023) | 1.08 | 530.3 | S19 |
Scheme consideration | 1.15 | 564.7 | S5 |
Last recorded close (third-party data) | 1.12 | 550.0 | S40 |
Valuation Measure At R1.15 Exit Price Details
| Valuation measure at R1.15 exit price | Value |
|---|---|
Reported NAV per share incl. NCI, FY2023 (cents) | 246.07 |
Attributable NAV per share, FY2023 (cents) | 96.6 |
Price / reported NAV (x) | 0.47 |
Price / attributable NAV (x) | 1.19 |
Normalised headline earnings, continuing, FY2023 (ZAR Mn) | 109.4 |
Exit equity value / normalised continuing headline earnings (x) | 5.2 |
Dividend history
| Dividend history | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
Gross dividend declared per share (cents) | 17 | 30 | 40 | 0 | 0 |
Dividends paid to AEEI shareholders (ZAR Mn) | — | 78.6 | 247.3 | 48.3 | 0 |
Reported NAV per share (cents) | 1,294.69 | 1,256.46 | 1,102.54 | 993.32 | 246.07 |
Attributable NAV per share (cents, derived) | 675.2 | 651.6 | 576.6 | 523.3 | 96.6 |
Analyst Conclusions
Management guidance and consensus
-
No guidance has been issued since the FY2023 prospects statement. That statement centred on fixing the banking position, delisting, and consolidating around profitable core assets [S1].
-
No consensus exists.
-
Expected growth depends mainly on squid catch rates, export prices and the rand, and secondarily on GC2T contract flow.
Bull case (three arguments)
-
A cleaner, profitable core. After the unbundling, the continuing group earned R122.1m of normalised PBT (16.6% margin) and R74.0m of operating cash flow in FY2023 [S1], free of AYO's losses.
-
A funded balance sheet. R290m of BTSA cash [S5] against at most R166.0m of scheme payout leaves AEEI debt-light with deployable capital. Premier's 15-year rights [S45] give long earnings visibility.
-
Legal upside. A Competition Tribunal ruling against the banks, building on the Commission's reported finding [S29], could restore normal banking and improve funding options and reputation.
Bear case (three arguments)
-
Single-species earnings risk. Fishing PBT margins ranged from 0.1% to 17.6% over FY2019 to FY2023, mainly because of squid [S1 to S3]. One bad squid season could wipe out group profit.
-
Banking and reputational exclusion persists. The SCA (Dec 2023), CAC (Jul 2023) and Tribunal (Jan 2025) all ruled against the group's interim relief [S26, S27]. This limits transactional banking, trade finance and M&A funding.
-
Opacity and governance. As an unlisted company controlled by a family trust, AEEI has published no financials since FY2023. Its own reporting showed inconsistencies [S1, S11]. Its track record shows attributable NAV per share falling 86% over four years [derived].
Catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Why it matters | Source |
|---|---|---|
| Competition Tribunal proceedings on the Commission's bank findings | Banking access and possible remedy | S28, S29 |
| Status of Equality Court and High Court bank cases; any ConCourt ruling | Legal resolution | S5, S26 |
| 2026 squid season catch rates and export prices | Main earnings driver | S1 |
| Any publication of FY2024 or FY2025 financial statements (e.g. CIPC filings) | Information on post-delisting performance | — |
| Deployment of BTSA proceeds (acquisitions, Premier investment, distributions) | Capital allocation | S5 |
| GC2T contract renewals (AU MNJTF, SAAF UIS) | Technology segment viability | S1 |
| Outcome of the R34.9m Proletariat claim against Marine Growers | Contingent liability | S5 |
| CTIJF 2027 announcement and ESP Afrika sponsorship | Events segment | S35 |
| Any further disposals under the portfolio consolidation strategy (Orleans, AfriNat, Tripos, biotech) | Simplification | S1 |
Analyst verdict
AEEI's five-year record is one of capital erosion inside a holding structure. At FY2019 it reported R6.4bn of total equity and R3.8bn of consolidated cash. By FY2023 total equity was R1.2bn and attributable equity R474m. The cash had mostly belonged to AYO's outside shareholders, chiefly the PIC, and it was spent through losses, dividends and the unbundling. Over the period AEEI paid R325.9m in dividends to its own shareholders (FY2020 to FY2022), while its attributable NAV per share fell from 675c to 97c. The R1.15 exit price looked like a deep discount to the headline NAV of 246c. Measured against attributable book of about 97c, it was in fact a modest premium. Minorities who exited were treated reasonably on that basis, as the independent expert concluded.
What remains is a small, controlled, fishing-centred group. Premier Fishing, 56.23% owned, has long-dated rights and a leading squid franchise, and it showed in FY2023 that it can earn mid-teens pre-tax margins in a good season. GC2T has become profitable. The other businesses are too small to matter much and mostly lose money at the segment level. Two forces dominate the outlook. One is environmental: squid biomass and the export price cycle. The other is institutional: the Sekunjalo group's continuing exclusion from mainstream banking. On the legal side the group has lost the interim battles so far, and the reported Commission finding is its main lever.
For an outside stakeholder (supplier, lender, partner or acquirer), AEEI should be assessed mainly as a holding vehicle for Premier Fishing. Counterparty diligence should focus on banking arrangements, related-party governance and the absence of audited post-FY2023 financials. Without new disclosure, our assessment is that the AEEI group carries high information and counterparty risk, with moderate operating quality at the Premier Fishing level.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Independence | Tenure / notes | Source |
|---|---|---|---|---|
Valentine Colleta Dzvova | Chief Executive Officer | Executive | CEO since at least Nov 2021; start date not publicly disclosed | S5, S2 |
Jowayne Shadwill van Wyk, CA(SA) | Chief Financial Officer | Executive | Executive director since at least FY2019 | S5, S3 |
Aziza Begum Amod | Chairman | Non-executive (not independent; concert party) | Chair since at least Dec 2019. Also chairs Premier Fishing and Marine Growers per Nov 2024 coverage [S34]. Holds 5,000 AEEI shares | S5, S3 |
Gamiem (Gaamiem) Colbie | Director | Non-executive | Director since at least FY2019 | S5, S3 |
Willem Johannes Raubenheimer | Lead Independent Director | Independent | Chaired the independent boards for the AYO unbundling and the 2024 scheme. Holds 612,250 shares (0.13%); treated as a concert party | S5 |
Carin-Lee Geuking-Cohausz | Director | Independent | Holds 11,134,662 shares (2.27%); concert party | S5 |
Membathisi Mdladlana | Director | Independent | Appointed 27 Aug 2021; former South African Minister of Labour | S2 |
Stephen Nthite | Director | Independent | Appointed 26 Aug 2021; member of the scheme independent board | S2, S5 |
Bongikhaya Qama | Director | Independent | Member of the scheme independent board | S5 |
Major Shareholders
| Rank | Holder | Shares | % | Notes | Source |
|---|---|---|---|---|---|
| 1 | Sekunjalo Investment Holdings (Pty) Ltd | 346,685,622 | 70.60 | Wholly owned by the Haraas Trust (Survé family beneficiaries) | S5 |
| 2 | Miramare Investments (Pty) Ltd | 25,859,927 | 5.27 | Altini family trusts; unrelated to directors | S5 |
| 3 | Altopiano Investments | 25,163,893 | 5.12 | 100% owned by Miramare (combined Altini interest 10.39%) | S5 |
| 4 | C-L Geuking-Cohausz (director) | 11,134,662 | 2.27 | Direct 9.61m; indirect non-beneficial 1.52m | S5 |
| 5 | W.J. Raubenheimer (director) | 612,250 | 0.13 | Direct and indirect | S5 |
| 6 | A. Amod (director) | 5,000 | 0.00 | — | S5 |
| — | Other public shareholders | about 81,560,000 | about 16.6 | Derived residual | S5 (derived) |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Relative positioning (qualitative) | Source |
|---|---|---|---|
Fishing (hake, pelagic, squid, lobster) | Sea Harvest Group (JSE: SHG) | Much larger, hake-led, internationally diversified (Australia, aquaculture) | S36 |
Fishing (pelagic, canned fish, squid, fishmeal) | Oceana Group (JSE: OCE) | Largest listed SA fishing group by revenue; Lucky Star canned fish; US menhaden (Daybrook) | S37 |
Fishing (hake, frozen foods) | Irvin & Johnson (part of AVI Ltd) | Major hake trawl and branded frozen-fish player; AEEI overlaps in hake | — |
Fishing (hake, pelagic) | Viking Fishing (owned by Sea Harvest since 2020) | Part of the Sea Harvest scale-up | S46 |
Abalone aquaculture | Sea Harvest's abalone business (via Aqunion) | Peer reported slow Chinese demand in FY2025 | S36 |
Abalone aquaculture | Other Western Cape farms (e.g. HIK Abalone, Abagold) | Competing Haliotis midae exporters; financials not public | — |
Black-controlled investment holding companies | Brimstone Investment Corp (JSE: BRT) | Closest listed analogue: holds 44.2% of Sea Harvest; INAV R2.38bn (Dec 2025) | S38 |
Black-controlled investment holding companies | African Rainbow Capital Investments; Hosken Consolidated Investments | — | — |
Defence C2 systems (GC2T) | Saab Grintek Defence; Reutech (Reunert) | Larger domestic defence electronics suppliers | — |
Cosmetics distribution (Orleans) | Multinational subsidiaries (e.g. L'Oréal South Africa) and other importers | Orleans is a small niche distributor (R38m revenue) | S1 |
Events (ESP Afrika) | Organisers of other major SA music festivals (e.g. Joy of Jazz) | CTIJF described in its own marketing as Africa's grandest gathering | S35 |
Travel (Tripos) | Large travel management companies (e.g. Flight Centre Travel Group, Tourvest) | Tripos is small (R20m revenue) | S1 |
Peer Comparison FY2023
| Metric | AEEI (FY Aug-2023, continuing) | Sea Harvest (FY Dec-2025) | Oceana (FY Sep-2025) | Brimstone (FY Dec-2025) |
|---|---|---|---|---|
Revenue (ZAR Mn) | 734.2 | 6,643.0 | 9,995.0 | Not applicable (holding company) |
Revenue growth YoY (%) | 26.9 | 20.2 | -0.7 | Not applicable |
Gross margin (%) | 44.1 | — | About 28 (R2.8bn gross profit) | Not applicable |
Pre-tax margin, normalised (%) | 16.6 | — | — | Not applicable |
Attributable profit (ZAR Mn) | -1245.7 (reported); normalised headline earnings 109.4 | — | 674 | — |
NAV / INAV (ZAR Mn) | 474.2 attributable | — | — | 2377.7 INAV |
Listing status | Delisted Apr 2024 | JSE listed | JSE, A2X, NSX listed | JSE listed |
Recent Developments
Public newsflow about AEEI itself over the strict 18-month window (mid-April 2025 to October 2026) is very thin. The register therefore runs from October 2023 to October 2026. Entries inside the 18-month window are marked ★. Related-party and investee events are included where they bear on AEEI's value.



